Proteintech

SF3B4 antibody

#10482-1-AP · western blot · $449

10
Citing papers
133
Combined citations
Supplier page Find this product

Research areas

RNA Research and Splicing7RNA modifications and cancer5Cancer-related gene regulation4Cancer-related molecular mechanisms research2Craniofacial Disorders and Treatments2Developmental Biology and Gene Regulation2Neurogenetic and Muscular Disorders Research1RNA and protein synthesis mechanisms1

Papers citing this product

1
Altered mRNA Splicing, Chondrocyte Gene Expression and Abnormal Skeletal Development due to SF3B4 Mutations in Rodriguez Acrofacial Dysostosis
PLoS Genetics·2016·60 cit.·DOI
2
SF3B4 promotes ovarian cancer progression by regulating alternative splicing of RAD52
Cell Death and Disease·2022·30 cit.·DOI
3
SF3B4 promotes Twist1 expression and clear cell renal cell carcinoma progression by facilitating the export of KLF 16 mRNA from the nucleus to the cytoplasm
Cell Death and Disease·2023·23 cit.·DOI
4
Human stem cell model of neural crest cell differentiation reveals a requirement of <scp>SF3B4</scp> in survival, maintenance, and differentiation
Developmental Dynamics·2025·5 cit.·DOI
5
SF3B4 regulates proliferation and apoptosis in hepatocellular carcinoma via alternative splicing and interaction with TRIM28 and SETD5
Journal of Translational Medicine·2025·5 cit.·DOI
6
<i>Sf3b4</i> mutation in <i>Xenopus tropicalis</i> causes RNA splicing defects followed by massive gene dysregulation that disrupt cranial neural crest development
bioRxiv (Cold Spring Harbor Laboratory)·2024·4 cit.·DOI
7
Splicing factor 3b subunit 4 (SF3b4) is mediated by EP300 and CREBBP to promote colorectal cancer (CRC) proliferation by enhancing autophagy
American Journal of Cancer Research·2025·3 cit.·DOI
8
Human stem cell model of neural crest cell differentiation reveals a requirement of SF3B4 in survival, maintenance, and differentiation
bioRxiv (Cold Spring Harbor Laboratory)·2024·2 cit.·DOI
9
Ouabain-mediated downregulation of ALKBH5 and IGF2BP2 inhibits the malignant progression of DLBCL
Frontiers in Pharmacology·2024·1 cit.·DOI
10
SF3B4 Regulated Alternative Splicing that Produced an Oncogenic Isoform of HOXA11-AS to Promote Glycolytic Reprogramming and ESCC Progression
Research Square·2023·DOI

Similar products

ProductVendorPricePapers
SF3B4 (E7R4H) Rabbit Monoclonal AntibodyRabbitCell Signaling Technology$175200
SF3B4 AntibodyRabbitCell Signaling Technology$31732
SF3B4 antibody — Evidence — PubIndex